These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 33075593

  • 1. Apraclonidine for the pharmacologic confirmation of acute Horner syndrome.
    Nguyen MTB, Farahvash A, Zhang A, Micieli JA.
    J Neurol Sci; 2020 Dec 15; 419():117190. PubMed ID: 33075593
    [Abstract] [Full Text] [Related]

  • 2. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A, Borruat FX.
    Klin Monbl Augenheilkd; 2008 May 15; 225(5):520-2. PubMed ID: 18454417
    [Abstract] [Full Text] [Related]

  • 3. Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke.
    Lebas M, Seror J, Debroucker T.
    J Neuroophthalmol; 2010 Mar 15; 30(1):12-7. PubMed ID: 20182200
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
    Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY.
    Am J Ophthalmol; 2006 Sep 15; 142(3):469-74. PubMed ID: 16935593
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
    Watts P, Satterfield D, Lim MK.
    J AAPOS; 2007 Jun 15; 11(3):282-3. PubMed ID: 17572343
    [Abstract] [Full Text] [Related]

  • 6. Effect of 0.5% apraclonidine on ptosis in Horner syndrome.
    Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL.
    Ophthalmic Plast Reconstr Surg; 2006 Jun 15; 22(1):53-5. PubMed ID: 16418668
    [Abstract] [Full Text] [Related]

  • 7. Early diagnosis of Horner syndrome using topical apraclonidine.
    Cooper-Knock J, Pepper I, Hodgson T, Sharrack B.
    J Neuroophthalmol; 2011 Sep 15; 31(3):214-6. PubMed ID: 21566530
    [Abstract] [Full Text] [Related]

  • 8. Positive Apraclonidine Test in Horner Syndrome Caused by Thalamic Hemorrhage.
    Kauh CY, Bursztyn LL.
    J Neuroophthalmol; 2015 Sep 15; 35(3):287-8. PubMed ID: 25768246
    [Abstract] [Full Text] [Related]

  • 9. [Usefulness of apraclonidine in the diagnosis of Horner syndrome].
    Pérez-Iñigo MA, González I, Fernández FJ, Díaz S, Ferrer C, Alias E, Honrubia FM.
    Arch Soc Esp Oftalmol; 2009 Feb 15; 84(2):105-8. PubMed ID: 19253181
    [Abstract] [Full Text] [Related]

  • 10. Topical apraclonidine in the diagnosis of suspected Horner syndrome.
    Freedman KA, Brown SM.
    J Neuroophthalmol; 2005 Jun 15; 25(2):83-5. PubMed ID: 15937427
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM, Aouchiche R, Freedman KA.
    Arch Ophthalmol; 2003 Aug 15; 121(8):1201-3. PubMed ID: 12912704
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.